Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cenetron Announces Launch of ARCHIVA BioLogistics

Published: Sunday, September 15, 2013
Last Updated: Sunday, September 15, 2013
Bookmark and Share
New Company to Specialize in Clinical Kit Manufacturing, Sample Logistics, and Sample Storage

Archiva Biologistics will focus on the design and manufacture of clinical collection kits, innovative laboratory requisition documents, sample logistics, and sample storage. All facets of Archiva are operationally linked and managed with GlobeSyncTM, an enterprise-wide 21-CFR-part 11 compliant Laboratory Information Management System, and Manufacturing software platform. GlobeSync is a proprietary software system and data portal developed at Cenetron Diagnostics.

Archiva will be housed in a recently completed 42,000 sq. foot facility, with state-of-the art manufacturing and sample storage capabilities.

Archiva customers are able to utilize individual services, such as kit building or sample storage, or can take advantage of a full complement of services from protocol review, kit design, sample logistics, sample storage, and testing.

New customers to Archiva include pharma and biotech companies, national reference laboratories, in-vitro diagnostic companies, and academic institutions.

Dwight DuBois, CEO, commented, “Archiva BioLogistics has been in development for several years. We recognized that high quality, cost containment, and maximum efficiency of clinical trial and reference laboratory work starts with flawless sample collection, transportation, and storage practices. We have come up with innovative, user-friendly answers to this common problem, based largely on feedback from customers with unmet needs.”

Vice President of Operations Brandon Harper commented, “By utilizing proven processes and best practices developed at Cenetron, Archiva is able to provide a complete sample management solution for a project of any size and for any location worldwide. Many of Archiva’s new clients are from outside our traditional pharma client base, and include diagnostic companies, specialty laboratories, and academic institutions.”

Cenetron Diagnostics is a premier provider of molecular laboratory services, providing support for anti-viral and oncology drug development programs, and pharmacogenomics. Founded in 1995, Cenetron has supported pivotal global trials in North and South America, Europe, Africa and the Pacific Rim. Cenetron's client list includes leading pharmaceutical clients in the United States and Europe.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Interpreting “Dark Matter” DNA
Scientists at the Gladstone Institutes have invented a new way to read and interpret the human genome.
A Programming Language for Living Cells
New language lets researchers design novel biological circuits.
The Epigenetics of Childhood Cancer
Qlucore software enables researchers to more easily study the genetic influences behind childhood cancer.
Mining Whole Exome Data to Improve Cancer Therapies
New tool interprets the raw data of whole exome tumor sequencing and then matches the cancer’s unique genetics to FDA-approved targeted treatments.
Pittcon 2016: Accelerating Innovation And Enhancing Productivity With Technology
Collaboration and externalization of data highlight evolving lab operations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!